Ajax-Loading

Sino Biopharmaceutical Ltd - Debt To Capital Ratio

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in Percent.

The item "Debt-To-Capital-Ratio" stands at 26.24 percent as of 06/30/2025, the highest value since 03/31/2024.

As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Debt To Capital Ratio" stands at 26.24 Percent. This represents an increase of 5.24 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.76 percentage points compared to the value the year prior.
The 1 year change in percentage points is 3.76.
The 3 year change in percentage points is -1.75.

The Serie's long term average value is 24.49 percent. It's latest available value, on 06/30/2025, is 1.75 percentage points higher, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 03/31/2022, to it's latest available value, on 06/30/2025, is +14.24.
The Serie's change in percentage points from it's maximum value, on 12/31/2022, to it's latest available value, on 06/30/2025, is -5.44.

Debt To Capital Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Debt To Capital Ratio905,699,262,464.00
LogoJohnson & Johnson - Debt To Capital Ratio486,508,953,600.00
LogoAbbVie Inc - Debt To Capital Ratio399,570,305,024.00
LogoRoche Holding AG - Debt To Capital Ratio317,433,206,677.55
LogoAstraZeneca PLC - Debt To Capital Ratio280,205,508,085.11